The Challenge of Change - Managing Excipients Control
Colorcon
| « Previous month | Next month » |
A trio of robots that can cope with the demands of vaccine handling and its packaging is ushering in new automation know how as part of a growing army of pharmaceutical production robotics.
Researchers have developed an alternative, cheaper method of producing insulin to help increase availability in emerging markets.
Lanxess has signalled its intentions for the future by investing €35m ($43m) to expand its German Basic Chemicals business unit in a move that is set to make the firm one of Europe’s biggest active pharmaceutical ingredients (API) producers.
Gold nanorods could be used to deliver an innate immune activator to tackle seasonal flu, H1N1 and other drug-resistant virus, according to research.
Compete against friends, colleagues and other readers in our exclusive, interactive map-based quiz, featuring questions about the Battelle / BIO report and recent events.
The EMA’s EudraVigilance post-authorisation module (EVPM) speeds detection of adverse drug reactions in some cases, according to a new study published in the journal Drug Safety
Cevec has exclusively licensed its transient CAP-T cell expression technology to Pevion for the manufacture and commercialisation of a protein antigen to vaccinate against an infectious disease.
DPT Laboratories has added bulk production and packaging capacity at its liquid and semi-solids plant in San Antonio, Texas in a continuation of its recent manufacturing reorganisation.
SOHM says separating pharmaceutical and nutritional production ops allows for greater scalability and faster manufacturing turnaround.
AMRI is reducing its US workforce 10 per cent and halting operations in one R&D lab at its facility in Rensselaer, New York as “softness” in the domestic market continues beyond its expectations.
Turkey’s pharmaceutical sector has signed up to the United Nations (UN) Global Compact, which promotes 10 principles related to areas including human rights, the environment and corruption.
Videojet has partnered with Systech to help companies meet emerging regulations by introducing track and trace equipment to the Brazilian market.
Adcock Ingram recorded an 11 per cent rise in profit in the first half of 2010 and is looking to continue this upwards trend through manufacturing expansions, plus local and overseas acquisitions.
Sepha has introduced EZ Blister II to meet rising demand from India, China and South America for an affordable, mobile blister packaging machine for clinical trial use.
US biotech Genzyme will pay $175m and cease some manufacturing operations at its facility in Allston, Massachusetts under final terms of Food and Drug Administration (FDA) consent decree.
The Indian Government plans to help medium sized pharmaceutical firms meet World Health Organisation (WHO) manufacturing plant standards with a new subsidy scheme.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Morphotek and Qualitest and resignations at Sigma-Aldrich and GenVec.
Invida has acquired a stake in Indonesia-based MUGI, giving it the local manufacturing presence needed to offer partners access to “a vast untapped market”.
The Irish drugmaking sector well-place to proper despite “challenges” as the pharma industry evolves, according to PharmaChemical Ireland (PCI).
US CMO Contract Pharmaceuticals (CPL) to close Buffalo plant by the end of 2011 on weak demand it attributes to pharmaceutical industry outsourcing cuts in downturn.
The European Chemical Industry Council (Cefic) has launched Grant-it to help member companies, particularly small and medium enterprises (SMEs), access European Union (EU) funding.
Abbott Laboratories has agreed to acquire Piramal’s healthcare solutions unit for an initial $2.12bn (€1.69bn), which it believes will create the largest pharma company in India.
in-PharmaTechnologist visualises the depth and distribution of the cuts Pfizer plans to make to its global manufacturing network.
Generics firm Apotex has launched a non-branded version of Pfizer’s mega-blockbusting cholesterol drug Lipitor in Canada
The US FDA should change its disclosure policy relating to manufacturing site inspections according to new draft recommendations by the Department of Health and Human Services (HHS) Transparency taskforce.
Eisai has opened a $100m (€81m), 65,000 sq ft commercial manufacturing and drug development site for intravenous treatments in Research Triangle Park (RTP), North Carolina, US.
An increase in demand for rayon fabric in China has led to higher prices for microcrystalline cellulose, an excipient for pharmaceuticals and a stabilizer for foods, drinks and personal care products.
Rumours have resurfaced that Indian generics firm Piramal Healthcare is in talks with Sanofi-Aventis and Pfizer about a potential takeover.
Indian CMO Kemwell says new manufacturing plant in Sweden will help meet customer demand for European production capacity.
Pfizer plans to close eight manufacturing sites and reduce operations at a further six by the end of 2015, leading to 6,000 job losses, as part of its reorganisation after acquiring Wyeth.
India and Thailand have requested the WHO ends its involvement with IMPACT, which the countries believe has conflicts of interest, and begin a programme focused on quality, safety and efficacy.
Xcellerex’ development and bioprocess manufacturing technology plays key role in creation of rapid, low-cost vaccine production system.
Concerns about the quality and capabilities of Baxter’s manufacturing operations have led to Halozyme issuing a notice of breach and stating it may terminate their Hylenex relationship.
in-PharmaTechnologist presents an overview of the UK pharma sector, using interactive maps and graphs to give an insight into its composition and how it has changed in recent years.
A 2D barcode system introduced to track drugs in Turkey crashed the day after it came online, according to Today’s Zaman .
Eurand says Zenpap important to Q1 growth that recent FDA move provides the drug with significant potential for further expansion in cystic fibrosis (CF) market
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a reshuffle at Daiichi Sankyo and appointments at Fate Therapeutics and 3-V Biosciences.
3M Drug Delivery Systems says new nasal MDI overcomes drip drawbacks using evaporating spray technology that can improve drug shelf-life.
Nigerian families call for halt on Trovan compensation payout until board overseeing claims gives more details of DNA identification process.
The IFMPA says that patients are the real victims of counterfeiters and has asked drugmakers to put this at the heart of their fight against fakers.
Microfluidics has posted an operating income of $106,000 (€84,000) in its results, the third consecutive quarter of profit, and is looking to expand products and services to continue growth.
Beike Biotechnology has opened a stem cell storage and processing facility at the 20,000 sq m regenerative medicine base in China, furthering the nation’s development in the field.
DSM Biologics says successful XD tech expansion paves way for smaller bioreactors that lowers cost of production facilities and, ultimately, of bio-drug manufacture.
A US Pharmacopeial Convention (USP) advisory panel has issued recommendations intended to improve drug compliance and minimise misuse by standardising prescription medication labels.
International demand for contract manufacturing helped India’s Jubilant Organosys finish fiscal 2010 with a quarter of growth.
Administration of Levitra (vardenafil) can increase Herceptin (trastuzumab) delivery to brain metastases, but not surrounding healthy tissue, increasing survival in mice, according to research.
Millipore says that rebounding Big Pharma spending and biotechnology drove first-quarter 2010 gains.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at the EMA, SCM Pharma, Silence Therapeutics and Akrimax Pharmaceuticals.
The FDA has found Jungbunzlauer Ladenburg to be in compliance with cGMP, furthering the company’s strategy to strengthen its presence in the pharma excipient market.
Albany Molecular Research (AMRI) says Q1 decline is due to “soft” demand for contract manufacturing services and trial materials, but is still confident of full-year growth.
Healthcare major Johnson & Johnson (J&J) has suspended operations at a Pennsylvania plant linked to a major product recall after US FDA inspection.
SpecBuyBuild.com has launched with the goal of significantly reducing the time, cost and uncertainty involved in building biotech and pharma systems and facilities.
A track and trace packaging system designed to integrate into existing operations, bringing companies into compliance with new regulations, has been launched by Crest Solutions and Eisai Machinery.
DSM Biologics says combining its XD platform with newly-acquired Rhobust chromatography platform will create high yield, low cost bio-manufacturing option.
KV Pharmaceutical has reported that an independent expert has re-inspected its facility and found it to be in compliance with good manufacturing practices (GMP).
The American Peptide Company (APC) says extra capacity at its protein production plant in Vista, California will help meet customer demand for large volume manufacturing.
Cambrex has posted a 55 per cent drop in operating profit in the first quarter, underpinned by the timing of orders, disruption to a customer’s supply chain and lower pricing of certain generic APIs.
in-PharmaTechnologist presents interactive maps of the pharma average wage, employment levels and number of establishments in the United States.
LyondellBasell announced Friday it had emerged from Chapter 11 bankruptcy under the ownership of a new parent company.
Rheumatoid arthritis (RA) sufferers may soon have a new treatment delivery option thanks to US delivery specialist Antares Pharma’s partnership with Canadian injectables specialist Uman Pharma.
Demand for high-tech packaging, H1N1 vaccine products and drug delivery technologies drove growth in Q1 says West Pharmaceutical Services.
In first quarter results Teva reported a year-on-year dip in active pharmaceutical ingredient (API) sales to third parties, from $158m (€120m) to $149m, but total net sales grew by sixteen per cent.
Evonik says new active pharmaceutical ingredient (API) plant in China is part of horizontal integration strategy.
The Office of the United States Trade Representative (USTR) has expressed particular concern about the proliferation of counterfeit drugs in countries including Brazil, China, India, Indonesia and Russia.
EyeGate Pharma is collaborating with GlaxoSmithKline (GSK) to evaluate the delivery if several of the big pharma’s therapies using an ocular delivery system.
DSM Biologics has entered into a partnership with the Australian government to build a 70,000 sq ft biopharmaceutical contract manufacturing facility.
| « Previous month | Next month » |